Signaturefd, LLC Chembio Diagnostics, Inc. Transaction History

Signaturefd, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$0.25 - $0.45 $1,175 - $2,115	4,700 Added 7.83%	64,700 $28,000
Q4 2022 Jan 27, 2023	SELL	$0.2 - $0.33 $1,860 - $3,069	-9,300 Reduced 13.42%	60,000 $13,000
Q3 2022 Nov 08, 2022	BUY	$0.35 - $1.1 $12,005 - $37,730	34,300 Added 98.0%	69,300 $25,000
Q2 2022 Aug 10, 2022	BUY	$0.45 - $0.8 $6,750 - $12,000	15,000 Added 75.0%	35,000 $23,000
Q3 2021 Oct 28, 2021	BUY	$2.06 - $5.34 $41,200 - $106,800	20,000 New	20,000 $50,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.